The effect of age on human striatal dopamine D2 receptors was investigated with positron emission tomography (PET) using [11C]raclopride as a radioligand. Twenty-one healthy volunteers aged from 20 to 81 years were studied. An equilibrium method was applied and two separate PET scans with different specific activities of [11C]raclopride were performed. The maximal number of receptors (Bmax) and their dissociation constant (Kd) were calculated using Scatchard analysis. There was an age-dependent decline in the Bmax (r = 0.49; p = 0.02) of striatal D2 receptors while the Kd remained unchanged. The results show that there is an age-related loss of striatal D2 receptors, which, together with other changes in the brain nigrostriatal dopaminergic system, may contribute to extrapyramidal symptoms associated with aging.
AntoniniASchwarzJOertelWLeendersK, (1992) The effect of dopaminergic treatment on striatal dopamine receptors in drug naive parkinsonian patients measured using PET and [11C]raclopride. In: Medical Applications of Cyclotorons VI (Voipio-PulkkiL-MWegeliusU, eds). Turku, Finland, Gillot Oy, pp. 83–84
2.
BaronJCMazièreBLoc'hCCambonHSgourropoulosPBonnetAMAgidY, (1986) Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy, J Cereb Blood Flow Metab6:131–136
3.
CarlssonAGottfriesC-GSvennerholmLAdolfssonROrelandLWinbladBAquiloniusS-M, (1980) Neurotransmitters in human brain analyzed post-mortem: Changes in normal aging, senile dementia and chronic alcoholism. In: Parkinson's Disease—Current Progress, Problems and Management (RinneUKKlinglerMStammG, eds). Amsterdam, Elsevier/North Holland Biomedical Press, pp. 121–133
4.
DeKeyserJEbingerGVauquelinG, (1990) Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol27:157–161
5.
FardeLHallHEhrinESedvallG, (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science231:258–261
6.
FardeLPauliSHallHErikssonLHalldinCHögbergTNilssonLSjögrenIStone-ElanderS, (1988) Stereoselective binding of “C-raclopride in living human brain—a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacol94:471–478
7.
FardeLErikssonLBlomqvistGHalldinC, (1989) Kinetic analysis of central 11C-raclopride binding to D2-dopamine receptors studied by PET—a comparison to the equilibrium analysis. J Cereb Blood Flow Metab8:696–708
8.
FardeLWieselF-AStone-ElanderSHalldinCNordströmA-LHallHSedvallG, (1990) D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission study with 11C-raclopride. Arch Gen Psychiatry47:213–219
9.
GarnettESNahmiasCFirnauG, (1984) Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography. Can J Neurol Sci11:174–179
10.
HallHFardeLSedvallG, (1988) Human dopamine receptor subtypes—in vitro binding analysis using [3H]SCH 23390 and [3H]raclopride. J Neural Transm73:7–21
11.
HessEJBrachaSKleinmanJECreeseI, (1987) Dopamine receptor subtype imbalance in schizophrenia. Life Sci40:1487–1497
12.
HornykiewiczO, (1983) Dopamine changes in the aging human brain. In: Aging, vol 23: Aging Brain and Ergot Alkaloids (AgnoliAGrepaldiGSpanoP-FTrabucchiM, eds). New York, Raven Press, pp. 9–14
13.
JenkynLRReevesAG, (1981) Neurologic signs in uncomplicated aging (senescence). Semin Neurol1:21–30
14.
LångströmBAntoniGGullbergPHalldinCNågrenKRimlandASvärdH, (1986) The synthesis of 1-11C-labelled ethyl, propyl, butyl and isobutyl iodides and examples of alkylation reactions. Appl Radiat Isot37:1141–1145
15.
MarshallJSJoyceJN, (1988) Basal ganglia dopamine receptor autoradiography and age-related movement disorders. Ann NY Acad Sci515:215–225
16.
MartinWRWPalmerMRPatlakCSCalneDB, (1989) Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol26:535–542
17.
MartresMPBouthenetMLSalesNSokoloffPSchwartsJC, (1985) Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpiride, a highly selective ligand. Science228:752–754
18.
MazièreBCoenenHHHalldinCNågrenKPikeVW, (1992) PET radioligands for dopamine receptors and reuptake sites: Chemistry and biochemistry. J Nucl Med Biol19:497–512
19.
McGeerPLMcGeerEGSuzukiJ, (1977) Aging and extrapyramidal function. Arch Neurol34:33–35
20.
MorganDGMarcussonJONybergPWesterPWinbladBGordonMNFinchCE, (1987) Divergent changes in D1 and D2 dopamine binding sites in human brain during aging. Neurobiol Aging8:195–201
21.
RinneJO, (1987) Brain muscarinic and dopaminergic receptors in the aging human brain. Brain Res404:162–168
22.
RinneJOLönnbergPMarjamäkiP, (1990) Age-dependent decline in human brain dopamine D-1 and D-2 receptors. Brain Res508:349–352
23.
SawleGVColebatchJGShahABrooksDJMarsdenCDFrackowiakRJS, (1990) Striatal function in normal aging—implications for Parkinson's disease. Ann Neurol28:799–804
24.
ScatchardG, (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci51:660–672
25.
SeemanPBzowejNHGuanH-GBergeronCBeckerLEReynoldsGPBirdEDRiedererPJellingerKWatanabeSTourtellotteWW, (1987) Human brain dopamine receptors in children and aging adults. Synapse1:399–404
26.
SeemanPGuanH-CNiznikHB, (1989) Endogenous dopamine lowers the dopamine D2 receptor density as measured by 3H-raclopride: Implications for positron emission tomography of the human brain. Synapse3:96–97
27.
SkreH, (1972) Neurological signs in a normal population. Acta Neurol Scand48:575–606
28.
SuharaTFukudaHInoueOItohTSuzukiKYamasakiTTatenoY, (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology103:41–45
29.
TedroffJAquiloniusS-MHartvigPLundqvistHGeeAGUhlinJLångströmB, (1988) Monoamine re-uptake sites in the human brain evaluated in vivo by means of 11C-nomifensine and positron emission tomography: The effects of age and Parkinson's disease. Acta Neurol Scand77:192–201
30.
WongDFWagnerHNJrDannalsRELinksJMFrostJJRavertHTWilsonAARosenbaumAEGjeddeADouglasKHPetronisJDFolsteinMFToungJKTBurnsHDKuharMJ, (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science226:1393–1396
31.
WongDFBroussolleEPWandGVillemangeVDannalsRFLinksJMZacurHAHarrisJNaiduSBraestrupC, (1988) In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann NY Acad Sci515:203–214
32.
YoungTLWongDFGoldmanSMinkinEChenCMatsumuraKScheffelUWagnerHNJr, (1991) Effects of endogenous dopamine on kinetics of [3H]N-Methylspiperone and [3H]Raclopride binding in the rat brain. Synapse9:188–194
